• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Inositol hexakisphosphate kinase 1 (IP6K1)

An entire inositol hexakisphosphate kinase 1 (IP6K1)?ORF inserted a 6xHis-SUMO-tag at the N-terminus was expressed in E.coli. The generated protein is the recombinant full-length fusion IP6K1 containing 1-441aa of human IP6K1. The SDS-PAGE analysis measured its purity up to 90%, and it has a calculated molecular mass of 66.2 kDa. In-stock IP6K1 proteins are offered now. This recombinant IP6K1 protein may be used to generate specific antibodies or in the studies of IP6K1-mediated signal transduction. IP6K1 is most abundantly expressed in the brain. IP6K1 and its product, 5-diphosphoinositol pentakisphosphate (5-IP7), act as key physiological determinants for suppression of presynaptic vesicle exocytosis and stimulation of endocytosis at central synapses. Besides, IP6K1 can directly bind and stimulate glycogen synthase kinase 3 (GSK3) in a non-catalytic manner. Min-Gyu Kim etc. showed that IP6K1 plays a role in the control of sensorimotor gating and short-term fear memory.

ACP02394

An entire inositol hexakisphosphate kinase 1 (IP6K1)?ORF inserted a 6xHis-SUMO-tag at the N-terminus was expressed in E.coli. The generated protein is the recombinant full-length fusion IP6K1 containing 1-441aa of human IP6K1. The SDS-PAGE analysis measured its purity up to 90%, and it has a calculated molecular mass of 66.2 kDa. In-stock IP6K1 proteins are offered now. This recombinant IP6K1 protein may be used to generate specific antibodies or in the studies of IP6K1-mediated signal transduction.
IP6K1 is most abundantly expressed in the brain. IP6K1 and its product, 5-diphosphoinositol pentakisphosphate (5-IP7), act as key physiological determinants for suppression of presynaptic vesicle exocytosis and stimulation of endocytosis at central synapses. Besides, IP6K1 can directly bind and stimulate glycogen synthase kinase 3 (GSK3) in a non-catalytic manner. Min-Gyu Kim etc. showed that IP6K1 plays a role in the control of sensorimotor gating and short-term fear memory.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP02394 Target NameIP6K1
FormLiquid or Lyophilized powderExpression SystemE.coli
Expression Range1-441aaMol Weight66.2kDa
Protein LengthFull lengthPurityGreater than 90% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ92551
Background Information
  • Uniprot Id

    Q92551

  • Target Species

    Human

  • Target Name

    IP6K1

  • Target Full Name

    Inositol hexakisphosphate kinase 1

  • Target Function

    Converts inositol hexakisphosphate (InsP6) to diphosphoinositol pentakisphosphate (InsP7/PP-InsP5). Converts 1,3,4,5,6-pentakisphosphate (InsP5) to PP-InsP4.

  • Target Subcellular Location

    Cytoplasm. Nucleus.

  • Target Protein Families

    Inositol phosphokinase (IPK) family

  • Target Research Area

    Signal Transduction

  • Target Synonyms

    ATP:1D myo inositol hexakisphosphate phosphotransferase; IHPK1; Inositol hexakisphosphate kinase 1; Inositol hexaphosphate kinase 1; InsP6; InsP6 kinase 1; Ip6k1; IP6K1_HUMAN; Itpk6; Pi uptake stimulator; PiUS

  • Target Background

    This gene encodes a member of the inositol phosphokinase family. The encoded protein may be responsible for the conversion of inositol hexakisphosphate (InsP6) to diphosphoinositol pentakisphosphate (InsP7/PP-InsP5). It may also convert 1, 3, 4, 5, 6-pentakisphosphate (InsP5) to PP-InsP4. Alternatively spliced transcript variants have been described.

Inquire Recombinant Human Inositol hexakisphosphate kinase 1 (IP6K1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification